Skip to content
Delayed ~15 min

XNCR XENCOR

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: not announced yet

What 16 analyst firms say about XENCOR: their latest ratings, price targets and how far the stock is from them. How it works

35.75 USD+1.70 (+4.99%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+13.5%to the avg target 40.58 USD+4.83 USD
Buy 13 · Hold 3 · Sell 0

16 rated views · 17 analyst/firm records · 16 firms

Latest report27 Oct 2026avg report date 9 Sep
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8048
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8059

Recent analyst activity · last 90 days

Our tracked history has 15 reports on XNCR from 10 analyst firms in the last 90 days (16 firms in the past year).

Comparing each firm's latest target with its previous one: 5 raised their price target, 2 left it unchanged and 2 have their first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: Cantor Fitzgerald raised its target from $44.00 (set 6 Aug 2026) to $70.00 on 27 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Bank of America SecuritiesAlec StranahanHold21 Sep 202626.00 USD
BarclaysEtzer DaroutBuy26 Oct 202645.00 USD
Canaccord GenuityJohn L NewmanBuy26 Feb 202638.00 USD
Cantor FitzgeraldPete StavropoulosBuy27 Oct 202670.00 USD
Cantor FitzgeraldSteve SeedhouseBuy6 Aug 202644.00 USD
JPMorganBrian ChengHold3 Sep 202621.00 USD
Leerink PartnersDaina M GrayboschBuy20 Jul 202625.00 USD
Piper SandlerEdward A TenthoffBuy5 Aug 2026—
Raymond JamesSean McCutcheonBuy1 Sep 202646.00 USD
RBC Capital MarketsLeonid TimashevBuy27 Oct 202643.00 USD
TD CowenTara BancroftBuy15 Jun 2026—
TruistGregory RenzaBuy27 Oct 202640.00 USD
WedbushDavid NierengartenBuy27 Oct 202645.00 USD
Weiss RatingsUnnamed analyst—21 Sep 2026—
Wells FargoDerek ArchilaBuy27 Oct 202644.00 USD
William BlairMatt PhippsBuy3 Aug 2026—
Data feed RESEARCHResearch TeamHold6 Jul 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 05:57 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.